These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


182 related items for PubMed ID: 14170787

  • 1. PAGET'S DISEASE OF BONE: CLINICAL AND METABOLIC OBSERVATIONS.
    DE DEUXCHAISNES CN, KRANE SM.
    Medicine (Baltimore); 1964 May; 43():233-66. PubMed ID: 14170787
    [No Abstract] [Full Text] [Related]

  • 2. Paget's disease of bone: problems and management.
    Haddad JG.
    Orthop Clin North Am; 1972 Nov; 3(3):775-86. PubMed ID: 4344935
    [No Abstract] [Full Text] [Related]

  • 3. EFFECTS OF ASPIRIN AND CORTICOSTEROIDS ON PAGET'S DISEASE OF BONE.
    HENNEMAN PH, DULL TA, AVIOLI LV, BASTOMSKY CH, LYNCH TN.
    Trans Stud Coll Physicians Phila; 1963 Jul; 31():10-25. PubMed ID: 14044623
    [No Abstract] [Full Text] [Related]

  • 4. Role of magnesium metabolism and the effects of fluoride therapy in Paget's disease of bone.
    Avioli LV, Berman M.
    J Clin Endocrinol Metab; 1968 May; 28(5):700-10. PubMed ID: 5653203
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP).
    Rashid M, Khairi A, Johnston C.
    Clin Orthop Relat Res; 1977 May; (127):94-105. PubMed ID: 410576
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. CORRELATION OF URINARY HYDROXYPROLINE, SERUM ALKALINE PHOSPHATASE AND SKELETAL CALCIUM TURNOVER.
    KLEIN L, LAFFERTY FW, PEARSON OH, CURTISS PH.
    Metabolism; 1964 Mar; 13():272-84. PubMed ID: 14127694
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of prolonged thyrocalcitonin administration on Paget's disease of bone.
    Haddad JG, Birge SJ, Avioli LV.
    N Engl J Med; 1970 Sep 10; 283(11):549-55. PubMed ID: 5450609
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The clinical and metabolic effects of porcine calcitonin on Paget's disease of bone.
    Shai F, Baker RK, Wallach S.
    J Clin Invest; 1971 Sep 10; 50(9):1927-40. PubMed ID: 4935444
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.